CTXR logo

CTXR
Citius Pharmaceuticals Inc

21,537
Mkt Cap
$15.37M
Volume
197,985.00
52W High
$2.97
52W Low
$0.63
PE Ratio
-0.19
CTXR Fundamentals
Price
$0.75
Prev Close
$0.7401
Open
$0.7304
50D MA
$0.9963
Beta
1.25
Avg. Volume
1.48M
EPS (Annual)
-$3.38
P/B
0.20
Rev/Employee
$0.00
Loading...
Loading...
Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite. The company was founded by Ralph Montrone, Leonard Mazur, Myron Holubiak on January 23, 2007 and is headquartered in Cranford, NJ.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
23

Frequently Asked Questions

What is Market Cap of Citius Pharmaceuticals Inc?
What is the 52-week high for Citius Pharmaceuticals Inc?
What is the 52-week low for Citius Pharmaceuticals Inc?
What is Citius Pharmaceuticals Inc stock price today?
What was Citius Pharmaceuticals Inc stock price yesterday?
What is the PE ratio of Citius Pharmaceuticals Inc?
What is the Price-to-Book ratio of Citius Pharmaceuticals Inc?
What is the 50-day moving average of Citius Pharmaceuticals Inc?
How many employess does Citius Pharmaceuticals Inc has?

Latest CTXR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.